Skip to content

Effects of a Virtual Reality Headset During Ultrasound-Guided Vacuum-Assisted Breast Biopsy on Pain - A Randomized Controlled Trial

Effects of a Virtual Reality Headset During Ultrasound-Guided Vacuum-Assisted Breast Biopsy on Pain - A Randomized Controlled Trial - VR_VSB_001

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00040017
Enrollment
100
Registered
2026-04-28
Start date
2026-06-29
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Evaluation or excision of breast lesions with benign or uncertain malignant potential

Interventions

Group 1: Intervention group: Patients undergoing ultrasound-guided vacuum-assisted breast biopsy while wearing the CE-marked VR headset HypnoVR®. Group 2: Control group: Patients undergoing the same p

Sponsors

Department für Frauengesundheit, Universitäts-Frauenklinik
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Sufficient knowledge of German (spoken and written) for independent communication and for understanding the study information and informed consent form Written informed consent after explanation Planned outpatient ultrasound-guided vacuum-assisted breast biopsy under local anaesthesia Sonographically clearly localizable lesion No contraindication to local anaesthetic

Exclusion criteria

Exclusion criteria: Insufficient knowledge of German (spoken and written) preventing understanding of the study information or provision of informed consent Expected lack of patient compliance or inability of the patient to understand the purpose and objectives of the clinical trial Missing patient consent Needle or claustrophobia Advanced dementia or cognitive impairment (clinical assessment: inability to provide informed consent or to follow instructions) Pregnancy Clinically relevant coagulation disorder (INR >1.5; platelet count <100,000/µL) Acute infection in the biopsy area with erythema Neurological pre-existing conditions (migraine, epilepsy, known motion sickness) Eye conditions significantly impairing the use of the VR headset (e.g., advanced macular degeneration, severe cataract) Positional vertigo

Design outcomes

Primary

MeasureTime frame
Pain intensity, measured using the Visual Analogue Scale (VAS) on a scale from 0 (no pain) to 10 (worst imaginable pain); assessed preoperatively, immediately postoperatively, approximately 30 minutes after the procedure, and one day after the procedure.

Secondary

MeasureTime frame
Anxiety (State-Trait Anxiety Inventory, STAI) Tolerance and tolerability of the VR headset (Simulator Sickness Questionnaire, SSQ) Patient satisfaction with care at the end of the hospital stay (ZUF-8) Staff satisfaction with the VR headset (MISS) Intraoperative stress (heart rate and skin conductance measurement via smartwatch) QUIPS questionnaire (Quality Improvement in Postoperative Pain Management questionnaire) Economic questionnaire (recommendation rate)

Countries

Germany

Contacts

Public ContactDr. med. Bettina Böer

Department für Frauengesundheit, Universitäts-Frauenklinik

bettina.boeer@med.uni-tuebingen.de+497071 29-82211

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 10, 2026